Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | 12.34M | $25.0M | 20.05% | -- | 2026-06-30 |
| MORGAN STANLEY | 9.85M | $20.0M | 16.01% | +898.2K | 2026-06-30 |
| BlackRock, Inc. | 5.20M | $10.0M | 8.45% | +3.81M | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.39M | $4.0M | 3.88% | +1.16M | 2026-06-30 |
| Bleichroeder LP | 2.00M | $4.0M | 3.25% | -- | 2026-06-30 |
| Hennion & Walsh Asset Management, Inc. | 1.85M | $3.0M | 3.00% | +236.1K | 2026-06-30 |
| Artia Global Partners LP | 1.81M | $3.0M | 2.94% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.18M | $2.0M | 1.91% | +28.3K | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 1.10M | $2.0M | 1.79% | -151.4K | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | 1.05M | $2.0M | 1.71% | -1.22M | 2026-06-30 |
